Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Colaboración

Año: 2017

Alonso, S; Riveiro-Barciela, M; Fernandez, I; Rincon, D; Real, Y; Llerena, S; Gea, F; Olveira, A; Fernandez-Carrillo, C; Polo, B; Carrion, JA; Gomez, A; Devesa, MJ; Baliellas, C; Castro, A; Ampuero, J; Granados, R; Pascasio, JM; Rubin, A; Salmeron, J; Badia, E; Planas, JMM; Lens, S; Turnes, J; Montero, JL; Buti, M; Esteban, R; Fernandez-Rodriguez, CM

Título: JOURNAL OF VIRAL HEPATITIS

• Q1